<DOC>
	<DOCNO>NCT01444755</DOCNO>
	<brief_summary>The aim study evaluate survival benefit neoadjuvant chemotherapy regimen patient resectable locally advanced gastric cancer comparison surgery alone .</brief_summary>
	<brief_title>The Effect Neoadjuvant Chemotherapy Locally Advanced Gastric Cancer</brief_title>
	<detailed_description>Adenocarcinoma stomach rank fourth commonly diagnose cancer second lead cause cancer-related death world . Radical resection free-margin gastrectomy extend lymphadenectomy preferred surgical strategy Japan Asian center . Unfortunately , one-half surgically treated patient gastric cancer achieve complete resection without residual disease ( R0 ) resection . Moreover , due , absence routine screening program gastric cancer , majority patient symptomatic time diagnosis country . Additionally , recent treatment strategy focus downsize decrease loco-regional recurrence . In reason , hypothesize preoperative chemotherapy may improve R0 resection rate disease free and/or overall survival rate .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>Histologically proven adenocarcinoma stomach T3 T4 N1 N2 M0 No evidence paraaortic retropancreatic lymph node metastasis , peritoneal dissemination Krukenberg tumor . No involvement esophagus &gt; 2cm An age 1890 year A Karnofsky Performance status 60100 % Eastern Cooperative Oncology Group ( ECOG ) performance status ( 02 ) No previous chemotherapy , radiotherapy malignancy . No previous surgery gastric cancer No evidence obstructive bleeding symptom . Adequate renal hepatic function Written inform consent Synchronous metachronous malignancy diagnose within 5 year Pregnancy lactation female patient Any immunosuppressive condition ( acquire iatrogenic ) Any infectious toxic mental condition prevent neoadjuvant therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Locally advanced gastric cancer</keyword>
	<keyword>neoadjuvant chemotherapy</keyword>
</DOC>